Breaking News Instant updates and real-time market news.

GIS

General Mills

$60.26

-0.4 (-0.66%)

, NEOG

Neogen

$68.56

0.04 (0.06%)

20:25
03/20/17
03/20
20:25
03/20/17
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include General Mills (GIS), consensus 71c... Neogen (NEOG), consensus 27c.

GIS

General Mills

$60.26

-0.4 (-0.66%)

NEOG

Neogen

$68.56

0.04 (0.06%)

  • 21

    Mar

  • 30

    May

GIS General Mills
$60.26

-0.4 (-0.66%)

01/11/17
SBSH
01/11/17
UPGRADE
Target $88
SBSH
Neutral
Kraft Heinz upgraded to Neutral from Sell at Citi
Citi analyst David Driscoll upgraded Kraft Heinz (KHC) to Neutral citing his belief that the company is "gearing up for" for a large accretive transaction in 2017. The analyst believes, however, that such an announcement is reflected in the current valuation. Driscoll favors General Mills (GIS) or Kellogg (K) as targets for Kraft. He raised his price target for the shares to $88 from $81.
02/15/17
DBAB
02/15/17
INITIATION
Target $61
DBAB
Hold
General Mills initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Rob Dickerson started General Mills with a Hold rating and $61 price target.
02/15/17
02/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kraft Heinz (KHC) and ConAgra Brands (CAG) were initiated with Buy ratings at Deutsche Bank. The firm also initiated Campbell Soup (CPB), J.M. Smucker (SJM) General Mills (GIS), Hershey (HSY), Kellogg (K) and Mondelez (MDLZ) with a Hold, as well as Pinnacle Foods (PF), Hostess Brands (TWNK) and Snyder's Lance (LNCE) with a Buy. 2. MasterCard (MA) and Visa (V) initiated with Buy ratings at Loop Capital by analyst Joseph Vafi. 3. Bioverativ (BIVV) initiated with an Outperform rating and $56 price target at Leerink by analyst Jason Gerberry. 4. Encana (ECA) initiated with an Overweight at JPMorgan. The firm also reinstated Cheniere Energy (LNG) and Cheniere Energy Partners LP (CQH) with Overweight ratings. 5. Blueprint Medicines (BPMC) initiated with an Overweight at Morgan Stanley by analyst Andrew Berens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
03/03/17
SBSH
03/03/17
NO CHANGE
SBSH
Kraft may look at General Mills, Kellogg, says Citi
In the wake of Kraft Heinz's (KHC) bid for Unilever (UN), Citi analyst Adam Spielman weighed in on the implications for consumer staples globally and said he thinks further M&A is likely, most probably in the U.S. He believes Kraft may still look at Unilever's food assets, or could target General Mills (GIS) or Kellogg (K). He also sees Mondelez (MDLZ) as a possible, but less likely, target for Kraft. Unilever could react by entering new categories, but Spielman sees it as more likely to reinforce existing strengths, "which points to" Colgate (CL) or Edgewell (EPC), he tells investors.
NEOG Neogen
$68.56

0.04 (0.06%)

03/24/16
ROTH
03/24/16
NO CHANGE
ROTH
Neogen should be bought on weakness, says Roth Capital
Roth Capital believes that Neogen is generating "rapid organic sales growth" which is being masked by adverse currency and sales mix trends. The firm expects the latter negative trends to significantly improve in the next few quarters, and it thinks the company has meaningful growth opportunities ahead. Roth recommends buying the stock on weakness and keeps a $68 price target and Buy rating on the shares.
07/25/16
ROTH
07/25/16
NO CHANGE
Target $68
ROTH
Buy
Neogen remains 'well positioned' to sustain rapid growth, says Roth Capital
Roth Capital analyst Anton Brenner believes Neogen remains "well positioned" to sustain rapid growth. While currency translation again adversely affected results in Q4 and some carryover to 2017 is likely, the analyst looks for sustained double-digit revenue growth and margin improvement over the next several years. Implementation of the Food Safety Modernization Act should be a significant tailwind, Brenner tells investors in a research note. He reiterates a Buy rating and $68 price target on the shares.
09/22/16
ROTH
09/22/16
NO CHANGE
Target $68
ROTH
Buy
Roth Capital remains a buyer of Neogen ahead of earnings
Roth Capital analyst Anton Brenner says that while adverse currency translation and a sales mix shift should adversely affect income comparisons in Q1, these short-term considerations should not undermine Neogen's extremely attractive outlook. The analyst expects that the implementation of the Food Safety Modernization Act and increasing food safety considerations in developing international markets will generate sustained double-digit revenue growth and improving profit margins over the next several years. He reiterates a Buy rating and $68 price target on Neogen's shares.
09/28/16
ROTH
09/28/16
NO CHANGE
Target $68
ROTH
Buy
Neogen outlook remains attractive, says Roth Capital
Roth Capital analyst Anton Brenner believes that while adverse currency translation and the removal of a product from the market adversely affected comparisons in Q1, Neogen's outlook for rapid growth remains intact. Moreover, he expects that the implementation of the Food Safety Modernization Act and increasing food safety considerations in developing international markets, in addition to periodic acquisitions, will generate sustainable double-digit revenue growth and improving profit margins over the next several years. The analyst reiterates a Buy rating and $68 price target on the shares.

TODAY'S FREE FLY STORIES

GM

General Motors

$45.42

-0.34 (-0.74%)

12:51
10/17/17
10/17
12:51
10/17/17
12:51
Hot Stocks
NY Governor says GM applying to test autonomous vehicles in state in early 2018 »

New York Governor Andrew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

IPXL

Impax

$19.95

-0.85 (-4.09%)

12:51
10/17/17
10/17
12:51
10/17/17
12:51
Recommendations
Impax analyst commentary  »

Impax combination with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

GOOGL

Alphabet Class A

$1,009.35

1.48 (0.15%)

12:50
10/17/17
10/17
12:50
10/17/17
12:50
Periodicals
Alphabet to unfold site in Toronto, Reuters reports »

Alphabet is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

WLL

Whiting Petroleum

$5.13

-0.135 (-2.57%)

12:45
10/17/17
10/17
12:45
10/17/17
12:45
Options
Whiting Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

MAR

Marriott

$114.75

-0.36 (-0.31%)

12:39
10/17/17
10/17
12:39
10/17/17
12:39
Hot Stocks
Marriott says Ed Ryan to retire as general counsel »

Marriott International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 30

    Nov

VSTM

Verastem

$4.21

-0.14 (-3.22%)

12:35
10/17/17
10/17
12:35
10/17/17
12:35
Conference/Events
Verastem management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

VALE

Vale

$10.28

-0.225 (-2.14%)

12:34
10/17/17
10/17
12:34
10/17/17
12:34
Periodicals
Vale seeks partner to invest in New Caledonia mine, FT reports »

Vale is seeking a partner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SB

Safe Bulkers

$3.21

-0.03 (-0.93%)

12:33
10/17/17
10/17
12:33
10/17/17
12:33
Conference/Events
Safe Bulkers management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

CREE

Cree

$29.28

-0.08 (-0.27%)

12:29
10/17/17
10/17
12:29
10/17/17
12:29
Technical Analysis
Technical Earnings Preview: Cree near top of range ahead of results »

The shares were trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

PYPL

PayPal

$67.31

-1.35 (-1.97%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Recommendations
PayPal analyst commentary  »

PayPal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 29

    Nov

LNG

Cheniere Energy

$48.20

0.48 (1.01%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Options
Cheniere Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
10/17/17
10/17
12:25
10/17/17
12:25
General news
U.S. corporate bond update: the calendar is relatively slim »

U.S. corporate bond…

CYTR

CytRx

$0.38

-0.0142 (-3.64%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
CytRx to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
Federal Reserve Bank of Philadelphia President speaks at summit »

Federal Reserve Bank of…

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
American Association for Cancer Research holds a webinar »

Webinar entitled,…

GOOG

Alphabet

$992.00

2.32 (0.23%)

12:20
10/17/17
10/17
12:20
10/17/17
12:20
Hot Stocks
Google refreshes Google Calendar for web »

Google said in a post to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 29

    Nov

JNJ

Johnson & Johnson

$139.15

3.03 (2.23%)

12:20
10/17/17
10/17
12:20
10/17/17
12:20
Periodicals
Appeals court throws out $72M verdict against J&J, St. Louis Post-Dispatch says »

The appeals court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

12:20
10/17/17
10/17
12:20
10/17/17
12:20
General news
Treasury's $40 B 4-week bill garnered solid results »

Treasury's $40 B…

SPX

S&P 500

12:19
10/17/17
10/17
12:19
10/17/17
12:19
Hot Stocks
Trump expected to pick Fed chair before Asia trip, CNBC reports »

President Trump is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
10/17/17
10/17
12:17
10/17/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
10/17/17
10/17
12:16
10/17/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$16.21

0.135 (0.84%)

12:15
10/17/17
10/17
12:15
10/17/17
12:15
Periodicals
Snap says advertising will stay main source of revenue, Bloomberg says »

Snap's head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

HBI

Hanesbrands

$23.28

-0.11 (-0.47%)

12:15
10/17/17
10/17
12:15
10/17/17
12:15
Options
HanesBrands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
10/17/17
10/17
12:15
10/17/17
12:15
General news
U.S. equities have been waffling »

U.S. equities have been…

BC

Brunswick

$57.82

0.2324 (0.40%)

12:14
10/17/17
10/17
12:14
10/17/17
12:14
Hot Stocks
Brunswick raises quarterly dividend 15% to 19c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.